Followers | 829 |
Posts | 119621 |
Boards Moderated | 14 |
Alias Born | 09/05/2002 |
Friday, September 14, 2018 10:12:43 AM
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143556549
Bonti’s product candidate is a type-E botulinum toxin, which is an altogether different animal from type-A botulinum toxins such as Botox and RVNC’s RT002.
I previously commented on Bonti in #msg-137948777 and #msg-137955390.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM